This invention relates to a composition containing quercetin, vitamin B3, and vitamin C. Also disclosed is a method of using the composition for enhancing physical or mental performance or treating various diseases or disorders.
대표청구항▼
What is claimed is: 1. A composition comprising quercetin, vitamin B3, and vitamin C as the only active ingredients, wherein a weight ratio between the quercetin, the vitamin B3, and the vitamin C is 1:0.02-1:0.2-2.5. 2. The composition of claim 1, wherein the weight ratio is 1:0.05-0.2:0.5-1.
What is claimed is: 1. A composition comprising quercetin, vitamin B3, and vitamin C as the only active ingredients, wherein a weight ratio between the quercetin, the vitamin B3, and the vitamin C is 1:0.02-1:0.2-2.5. 2. The composition of claim 1, wherein the weight ratio is 1:0.05-0.2:0.5-1. 3. The composition of claim 1, wherein the weight ratio is 1:0.1-0.2:0.5-1. 4. The composition of claim 1, wherein the weight ratio is 1:0.04:1. 5. The composition of claim 1, wherein the weight ratio is 1:0.08:1. 6. The composition of claim 1, wherein the composition is in dry form. 7. The composition of claim 1, wherein the composition is in liquid form. 8. The composition of claim 1, wherein the composition is a food product selected from the group consisting of tea, soft drink, juice, milk, coffee, jelly, ice cream, yogurt, cookie, cereal, chocolate, and snack bar. 9. The composition of claim 8, wherein the food product is tea, soft drink, juice, or snack bar. 10. The composition of claim 1, wherein the composition is a dietary supplement or a pharmaceutical formulation. 11. The composition of claim 10, wherein the composition is a tablet, a capsule, a soft chew, or a gel. 12. The composition of claim 1, wherein the vitamin B3 is niacinamide. 13. The composition of claim 1, wherein the vitamin B3 is nicotinic acid. 14. A composition comprising quercetin, vitamin B3, vitamin C, and another agent as the only active ingredients, wherein a weight ratio between the quercetin, the vitamin B3, and the vitamin C is 1:0.02-1:0.2-2.5, and the other agent is selected from the group consisting of genistein, genistin, curcumin, reserveratrol, isoquercetin, epigallocatechin gallate (EGCG), eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and a combination thereof. 15. The composition of claim 14, wherein the other agent is a combination of isoquercetin, EGCG, EPA, and DHA. 16. The composition of claim 14, wherein the weight ratio is 1:0.05-0.2:0.5-1. 17. The composition of claim 14, wherein the weight ratio is 1:0.1-0.2:0.5-1. 18. The composition of claim 14, wherein the weight ratio is 1:0.04:1. 19. The composition of claim 14, wherein the weight ratio is 1:0.08:1. 20. The composition of claim 14, wherein the composition is in dry form. 21. The composition of claim 14, wherein the composition is in liquid form. 22. The composition of claim 14, wherein the composition is a food product selected from the group consisting of tea, soft drink, juice, milk, coffee, jelly, ice cream, yogurt, cookie, cereal, chocolate, and snack bar. 23. The composition of claim 14, wherein the vitamin B3 is niacinamide. 24. The composition of claim 14, wherein the vitamin B3 is nicotinic acid. 25. The composition of claim 14, wherein the composition is a dietary supplement or a pharmaceutical formulation. 26. The composition of claim 25, wherein the composition is a tablet, a capsule, a soft chew, or a gel.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (19)
Riley Patricia A. ; Christakis George, Acetylsalicylic acid and micronutrient supplementation for nutritional losses and coronary heart disease.
Dudrick Stanley J. (702 Pine St. Philadelphia PA 19106) Guinn Edward J. (23 S. Brokenfern The Woodlands TX 77380) Gerlich Stanley J. (11434 Loyola Cypress TX 77429) Feste Andrew S. (4219 S. Judson Ho, Amino acid nutritional supplement and regimen for enhancing physical performance through sound nutrition.
Daniel O. Lukaczer ; Gary K. Darland ; DeAnn J. Liska ; Tracey A. Irving ; Jeffrey S. Bland, Dietary supplements for treating fatigue-related syndromes.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.